Trends and Updates in IBD

Appraising the Therapeutic Armamentarium in Moderate and Severe Disease

Course Description

Physicians need further education to fully understand and implement current advanced therapies and distinguish the pathways of disease and targets addressed by newer therapies. This educational activity will provide key clinical data on new and emerging treatments, focusing on the Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway in the context of evolving understanding of disease immunopathogenesis.

Jointly provided by Postgraduate Institute for Medicine and Integritas Communications.

 

This activity has been supported by independent educational grant from Gilead Sciences, Inc.

Image Webcast
Trends and Updates in IBD: Appraising the Therapeutic Armamentarium in Moderate and Severe Disease

Snapshot of IBD Today

Bruce E. Sands, MD, MS; Thomas A. Ullman, MD
MODULE 1
Begin Activity

credit amount 0.25

credit type AMA PRA

expiration 08/23/2020

Image Webcast
Trends and Updates in IBD: Appraising the Therapeutic Armamentarium in Moderate and Severe Disease

The Current and Emerging Treatment Landscape of IBD

Bruce E. Sands, MD, MS; Thomas A. Ullman, MD
MODULE 2
Begin Activity

credit amount 0.25

credit type AMA PRA

expiration 08/23/2020